^a Tested in dextrose 5%.

^b Tested in sodium chloride 0.9%.

^c Tested in sterile water for injection.

^d Furosemide 0.5 mL injected in the Y-site port of a running infusion of labetalol hydrochloride in dextrose 5%.

^e Tested in Ringer’s injection, lactated.

^f Trimethoprim component. Trimethoprim in a 1:5 fixed-ratio concentration with sulfamethoxazole.

^g Tested in both dextrose 5% and sodium chloride 0.9%.

^h Ceftolozane component. Ceftolozane in a 2:1 fixed-ratio concentration with tazobactam.

ⁱ Meropenem component. Meropenem in a 1:1 fixed-ratio concentration with vaborbactam.

^j Test performed using the formulation WITH edetate disodium.

^k Salt not specified.

^l Imipenem component. Imipenem in a 2:2:1 fixed-ratio concentration with cilastatin and relebactam.

^m Not specified whether concentration refers to potassium or phosphates content.

ⁿ Sulbactam component. Sulbactam in a 1:1 fixed-ratio concentration with durlobactam.